{"id":"NCT01582061","sponsor":"Novartis Pharmaceuticals","briefTitle":"An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.","officialTitle":"An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease (Seascape).","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-08-16","primaryCompletion":"2017-01-26","completion":"2017-01-26","firstPosted":"2012-04-20","resultsPosted":"2018-06-19","lastUpdate":"2018-06-19"},"enrollment":104,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Cushing's Disease"],"interventions":[{"type":"DRUG","name":"Pasireotide sub-cutaneous","otherNames":["SOM230 sub-cutaneous"]}],"arms":[{"label":"Pasireotide 600 μg","type":"EXPERIMENTAL"},{"label":"Pasireotide 900 μg","type":"EXPERIMENTAL"}],"summary":"This study provided access to pasireotide sc in patients with Cushing's disease.and provided additional information for safety and efficacy of pasireotide s.c.","primaryOutcome":{"measure":"Percentage of Patients With a Drug-related Adverse Event That is Recorded as Grade 3 or 4 or as a Serious Adverse Event (SAE)","timeFrame":"Baseline up to approximately 256 weeks","effectByArm":[{"arm":"600 µg Bid - All Grades","deltaMin":53.1,"sd":null},{"arm":"600 μg - Grades 3/4","deltaMin":53.1,"sd":null},{"arm":"900 μg - All Grades","deltaMin":29.1,"sd":null},{"arm":"900 μg - Grades 3/4","deltaMin":27.3,"sd":null},{"arm":"All Patients - All Grades","deltaMin":40.4,"sd":null},{"arm":"All Patients - Grades 3/4","deltaMin":39.4,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":65,"countries":["United States","Brazil","Czechia","Germany","Greece","Lebanon","Romania","Russia","South Korea","Spain","Thailand"]},"refs":{"pmids":["31379734"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":49},"commonTop":["Diarrhoea","Nausea","Hyperglycaemia","Headache","Cholelithiasis"]}}